{
  "created_at": "Sun Aug 22 6:42:14 +0000 2021",
  "id_str": "1429330023220133896",
  "full_text": "The FDA is expected to grant full approval of Pfizer's Covid-19 vaccine next week. The two-dose shot was first cleared in December by the agency on an emergency use basis. https://t.co/woNF2MBPWq",
  "display_text_range": [
    0,
    195
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/woNF2MBPWq",
        "expanded_url": "https://on.wsj.com/3gpio3l",
        "display_url": "on.wsj.com/3gpio3l",
        "indices": [
          172,
          195
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 41,
  "favorite_count": 79,
  "possibly_sensitive": false,
  "original_created_at": "Sun Aug 22 06:30:07 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "FDAは来週、ファイザー社のCovid-19ワクチンの完全な承認を与える見込みです。この2回接種のワクチンは、12月に緊急用としてFDAから初めて承認されたものである。https://t.co/woNF2MBPWq"
    },
    {
      "locale": "zh",
      "full_text": "美国食品和药物管理局预计将在下周对辉瑞公司的Covid-19疫苗进行全面批准。该机构在12月首次以紧急使用的方式批准了这种两剂量的注射。https://t.co/woNF2MBPWq"
    },
    {
      "locale": "zh-Hant",
      "full_text": "美國食品和藥物管理局預計將在下週對輝瑞公司的Covid-19疫苗進行全面批准。該機構在12月首次以緊急使用的方式批准了這種兩劑量的注射。https://t.co/woNF2MBPWq"
    }
  ]
}